“New drugs: Kids come first”: Children should be included in trials of new biological treatments
about
Biologics in children's autoimmune disorders: efficacy and safety.Juvenile idiopathic arthritis: management and therapeutic options.The impact of induction therapy with three doses of infliximab on deep histological healing in paediatric patients with active Crohn's disease.Profile of infliximab in the treatment of pediatric Crohn's disease.
P2860
“New drugs: Kids come first”: Children should be included in trials of new biological treatments
description
im September 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2007
@uk
name
“New drugs: Kids come first”: ...... s of new biological treatments
@en
“New drugs: Kids come first”: ...... s of new biological treatments
@nl
type
label
“New drugs: Kids come first”: ...... s of new biological treatments
@en
“New drugs: Kids come first”: ...... s of new biological treatments
@nl
prefLabel
“New drugs: Kids come first”: ...... s of new biological treatments
@en
“New drugs: Kids come first”: ...... s of new biological treatments
@nl
P2860
P356
P1476
“New drugs: Kids come first”: ...... s of new biological treatments
@en
P2093
Alessio Morley-Fletcher
P2860
P304
P356
10.1002/IBD.20045
P577
2007-09-01T00:00:00Z